Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BacStar

Financiado

Cerrado

Design, Build and Test of novel bacteria-delivered proteins for cancer therapy

Conventional cancer therapies have many limitations that could potentially be overcome using engineered tumour targeting bacteria as cancer therapeutics. These bacteria have been shown to selectively grow in tumours where they can... ver más

30/06/2026

UCC

Presupuesto desconocido

Líder del proyecto

UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-01-01

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021 ExpectedOutcome:

I+D

Cerrada hace 3 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UCC

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

InCanTeSiMo Intelligent cancer therapy with synthetic biology methods 2M€ Cerrado

BIO2014-60305-R INGENIERIA DE E. COLI MEDIANTE BIOLOGIA SINTETICA PARA LA UN... 278K€ Cerrado

FJC2021-047068-I Generation of a cell contact response circuit in E.coli for... 65K€ Cerrado

BES-2015-073850 INGENIERIA DE E. COLI MEDIANTE BIOLOGIA SINTETICA PARA LA UN... 93K€ Cerrado

BIO2017-89081-R AVANCES EN EL DESARROLLO MEDIANTE BIOLOGIA SINTETICA DE BACT... 230K€ Cerrado

GENETHESIS Gene Therapy Modeling Synthetic DNA Delivery Systems 100K€ Cerrado

Duración del proyecto: 41 meses Fecha Inicio: 2023-01-01
Fecha Fin: 2026-06-30

Líder del proyecto

UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Conventional cancer therapies have many limitations that could potentially be overcome using engineered tumour targeting bacteria as cancer therapeutics. These bacteria have been shown to selectively grow in tumours where they can produce and deliver therapeutic biomolecules (proteins) extracellularly in the tumour microenvironment. However, the delivery of these biomolecules into the cytoplasm of targeted tumour cells remains a challenge, limiting the clinical translation of these therapies. BacStar aims to address delivery challenges by designing multi-part, multifunctional proteins that transport themselves from the interior of the bacterium into the cytoplasm of cancer cells where they can exert therapeutic action. These proteins will integrate protein motifs for transport (using novel cell penetrating peptides) and anticancer activity, which will be assembled using recently developed computational protein design workflows. A modular design-build-test synthetic biology approach will facilitate measurability and experimental throughput. Novel proteins will be tested in vitro and in vivo with high-throughput methods available at host labs. This interdisciplinary approach is enabled by leveraging cutting-edge expertise and technologies in computational protein design from the Bhardwaj and Baker Lab at the Institute for Protein Design, UW (USA) and in bacterial cancer therapy available at the Tangney Lab, UCC (Ireland). An international intersectoral placement at Prokarium (UK) will support the clinical translation of outputs from this project and build my expertise in translational research, which will inform the commercialisation route of this and future projects. My long-term career aim is to develop bacteria-delivered protein therapeutics. BacStar is a significant career opportunity to transition to independence with the active support of world leaders in their fields and gaining industry R&D experience which is key for the advance of these biotherapeutics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores